PNV - Banter and General Comments, page-11896

The claims of better cosmetic outcomes and faster healing are very weak which is one reason NICE rejected it... twice. It does have a place in conjunction with wider meshed grafting which increases coverage of split skin grafts in massive burns. But in the developed world that's not a huge market. So Avita has been trying to persuade surgeons to use it on small superficial burns where is brings no benefit to patients but does benefit Avita and the service providers in fees and charges. Success in that department seems limited. It has very little place in trauma as well since usually the areas to be covered don't require wider meshed grafting. In any event a surgeon could simply do the same thing at tiny cost by harvesting a piece of skin, dissolving it in some trypsin in a kidney dish and spraying it on the graft from a syringe. USD10 not USD6000... job done